Arylquinoziline derivatives as alpha2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea
US-2022218677-A1 · Jul 14, 2022 · US
This page is not indexed by search engines while we improve data quality.
Patent family 66476527
This patent family groups 1 related publication across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 66476527 |
| Family type | — |
| Earliest priority | May 9, 2019 |
| First filing country | US |
| Member publications | 1 |
| Countries | US |
| Representative publication | US2022218677A1 — Arylquinoziline derivatives as alpha2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea |
Representative publication
Best representative member for this family based on priority and filing country.
US2022218677A1 — Arylquinoziline derivatives as alpha2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apnea (published Jul 14, 2022)
Member publications
Related publications in this family.